French | English

Home : Investors > Publications > Quarterly financial information

Contact us

Questions about the Group, products, the financial statements?

> Please fill in this form

Where to meet us?

> View the Group's agenda

Quarterly financial information

09/02/2010

BioAlliance Pharma announces its consolidated turnover for 2009 - A doubling in recurring revenues (PDF - 49 Ko)

21/10/2009

Q3 2009: Strong Sales Growth and Significant Progress in Clinical Development (PDF - 114 Ko)

22/07/2009

Turnover of Q2 2009: sustained sales growth and an NDA for Loramyc® in the USA (PDF - 86 Ko)

29/04/2009

Q1 2009 turnover: Sustained growth and a solid cash situation - Significant portfolio developments (PDF - 87 Ko)

10/02/2009

2008 consolidated turnover: + 134% - Strong sales growth, A pro-active partnering strategy (PDF - 99 Ko)

01/03/2006

Revenues - fourth quarter 2005 (in French) (PDF - 83 Ko)

01/06/2006

Revenues - first quarter 2006 (in French) (PDF - 102 Ko)

01/10/2006

Revenues - second quarter 2006 (in French) (PDF - 102 Ko)

« Previous Next » 1 | 2 | 3 | 4